Smoking Cessation in Lung Cancer Screening: The Latest Randomized Controlled Trial Evidence

Regulating Artificial Intelligence

… regulate the use of artificial intelligence in clinical research? How likely is it that AI could lead us to erroneous … data-driven tools. ILCN:  Another potential use for AI in research could be evaluating disease burden. To what extent do … Singh:  FDA recognizes the interest and potential for AI research tools to aid in disease evaluation, such as with …

Funding Opportunities for Innovative Multidisciplinary Cancer Research Teams

… Opportunities for Innovative Multidisciplinary Cancer Research Teams …

Tobacco Control Impacts Everyone in Respiratory Medicine, JTO CRR Editor Says

… In a Q&A with ILCN, new JTO Clinical and Research Reports Editor-in-Chief Dr. Emily Stone discusses her … and the importance of open-access journals in elevating research globally. … Tobacco Control Impacts Everyone in …

Cultural Context Largely Absent in Advanced Care Planning Research, Guidelines

… Cultural Context Largely Absent in Advanced Care Planning Research, Guidelines …

Tobacco Control Committee Chair Discusses Recent Legislative, Research Developments

… Control Committee Chair Discusses Recent Legislative, Research Developments … Erin Jungmeyer …

Translating Early Research to Adapt CAR T-Cell Therapy to Solid Tumors

Narrow Focus Allows Pragmatica-Lung Trial to Minimize Eligibility Criteria, Significantly Reduce Data Collection, Researcher Says

… Criteria, Significantly Reduce Data Collection, Researcher Says … Erin Jungmeyer …

Passing of The Baton—On the Death of Patient Research Advocates

… says. … Passing of The Baton—On the Death of Patient Research Advocates … Angus Pratt …

Real-World Data from Taiwan Shows Stage Shift Has Improved Lung Cancer Survival Rates

… Researchers say increased screening of at-risk populations, …

Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture

US FDA’s Review of Single-Country ‘Me Too’ Drugs: A Clinical Trialist Perspective

… of care and limited resources to review applications, researchers say they support the agency’s decision not to …